Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sural Nerve | 1 | 2011 | 47 | 0.360 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 53 | 0.350 |
Why?
|
| Electrophysiology | 1 | 2011 | 271 | 0.340 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 122 | 0.330 |
Why?
|
| Multiple Sclerosis | 6 | 2009 | 329 | 0.240 |
Why?
|
| Myelin Basic Protein | 4 | 2009 | 68 | 0.240 |
Why?
|
| Myotonic Dystrophy | 2 | 2012 | 149 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 946 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 63 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2009 | 1726 | 0.100 |
Why?
|
| Reflex | 1 | 2011 | 51 | 0.090 |
Why?
|
| Neural Conduction | 1 | 2011 | 92 | 0.090 |
Why?
|
| Interferon-beta | 1 | 2009 | 52 | 0.080 |
Why?
|
| Osteopontin | 1 | 2009 | 48 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2009 | 119 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2009 | 472 | 0.080 |
Why?
|
| Action Potentials | 1 | 2011 | 502 | 0.070 |
Why?
|
| Pain | 1 | 2011 | 451 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 216 | 0.070 |
Why?
|
| Peptide Fragments | 3 | 2009 | 780 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 701 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 573 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2057 | 0.060 |
Why?
|
| Gene Expression | 1 | 2010 | 1560 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 61 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2003 | 25 | 0.050 |
Why?
|
| Autoantigens | 1 | 2004 | 118 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 264 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 199 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1446 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 63 | 0.050 |
Why?
|
| Herpesvirus 6, Human | 1 | 2002 | 58 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 504 | 0.050 |
Why?
|
| Middle Aged | 6 | 2012 | 26928 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2002 | 480 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 236 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2002 | 347 | 0.040 |
Why?
|
| Adult | 6 | 2012 | 29627 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6598 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4395 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 9053 | 0.030 |
Why?
|
| Male | 7 | 2012 | 61523 | 0.030 |
Why?
|
| Vaccination | 1 | 2002 | 963 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 1153 | 0.030 |
Why?
|
| Female | 7 | 2012 | 66803 | 0.030 |
Why?
|
| Cyclin D3 | 1 | 2012 | 10 | 0.030 |
Why?
|
| Thiadiazoles | 1 | 2012 | 5 | 0.030 |
Why?
|
| Lymphocyte Count | 2 | 2004 | 118 | 0.030 |
Why?
|
| Aged | 1 | 2011 | 19871 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2012 | 57 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 57 | 0.030 |
Why?
|
| Humans | 9 | 2012 | 125186 | 0.030 |
Why?
|
| Lithium | 1 | 2012 | 66 | 0.030 |
Why?
|
| CHO Cells | 1 | 2012 | 169 | 0.030 |
Why?
|
| Cricetinae | 1 | 2012 | 422 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 94 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2012 | 75 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 256 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2009 | 3056 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 358 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 49 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2010 | 48 | 0.020 |
Why?
|
| Mice | 3 | 2012 | 17631 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2009 | 35 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2009 | 31 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2009 | 73 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1631 | 0.020 |
Why?
|
| Interleukins | 1 | 2009 | 120 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 352 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 867 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 420 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 221 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 354 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2009 | 370 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 847 | 0.020 |
Why?
|
| Animals | 3 | 2012 | 34230 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 2397 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2004 | 104 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2004 | 84 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 97 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 2003 | 38 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2003 | 43 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2003 | 77 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 229 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2004 | 329 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 166 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 781 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3348 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1898 | 0.010 |
Why?
|
| Virion | 1 | 2002 | 147 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 825 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4404 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 2002 | 142 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 397 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 683 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1290 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 218 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 541 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 2756 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2714 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 1396 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3892 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 2067 | 0.010 |
Why?
|
| Brain | 1 | 2002 | 2998 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 12392 | 0.000 |
Why?
|